Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 33 (6) , 395-402
- https://doi.org/10.1016/j.diabet.2007.10.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial BiogenesisCell Metabolism, 2007
- Role of the α2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivoJournal of Applied Physiology, 2006
- Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ AgonistsJournal of Biological Chemistry, 2006
- AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytesBiochemical and Biophysical Research Communications, 2005
- Over-expression of AMP-activated protein kinase impairs pancreatic β-cell function in vivoJournal of Endocrinology, 2005
- Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretionAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse modelsBiochemical Society Transactions, 2003
- Selective suppression of AMP-activated protein kinase in skeletal muscle: update on ‘lazy mice’Biochemical Society Transactions, 2003
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001